Blue Owl Capital Holdings LP ELDN ELEDON PHARMACEUTICALS INC

Ownership history in Blue Owl Capital Holdings LP  ·  6 quarters on record

AI Ownership Summary

Blue Owl Capital Holdings LP reported ELEDON PHARMACEUTICALS INC (ELDN) in 6 quarterly 13F filings from 2024 Q4 through 2026 Q1. Peak portfolio weight reached 1.99% in 2025 Q1. The latest visible filing shows ELDN at 1.18% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this ELDN ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Blue Owl Capital Holdings LP's position in ELEDON PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

ELDN was reported at 1.18% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
1.99% in 2025 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Blue Owl Capital Holdings LP held ELDN — position size vs. price
% of Fund (quarterly)    ELDN price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 6 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED 26.4% +26.0% 1,419,912 -510,000 -26.4% 1.18% $4.4M 2026-05-14 $3.95
2025 Q4 ADDED 1,929,912 +950,000 +96.9% 0.22% $2.9M 2026-02-09 $2.13
2025 Q3 REDUCED 26.3% -40.1% 979,912 -350,000 -26.3% 0.79% $2.54B 2025-11-12 $1.89
2025 Q2 REDUCED 26.9% -6.3% 1,329,912 -490,000 -26.9% 1.16% $3.60B 2025-08-11 $2.71
2025 Q1 REDUCED 7.1% -20.1% 1,819,912 -140,000 -7.1% 1.99% $6.17B 2025-05-15 $2.89
2024 Q4 INITIATED 1,959,912 1.86% $8.07B 2025-02-14 $4.53

FAQ About Blue Owl Capital Holdings LP and ELDN

These are the practical questions this page is built to answer before you even open the full history table.

How long has Blue Owl Capital Holdings LP reported owning ELDN?

Blue Owl Capital Holdings LP reported ELDN across 6 quarterly 13F filings, from 2024 Q4 through 2026 Q1.

What was the largest reported ELDN position in Blue Owl Capital Holdings LP's portfolio?

The largest reported portfolio weight for ELDN was 1.99% in 2025 Q1.

What is the latest reported ELDN position on this page?

The most recent filing on this page is 2026 Q1, when Blue Owl Capital Holdings LP reported 1,419,912 shares, equal to 1.18% of portfolio, with an estimated market value of $4.4M.

What does the chart on this ELDN ownership page compare?

The chart compares Blue Owl Capital Holdings LP's quarterly ELDN portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Blue Owl Capital Holdings LP time their ELDN position?

Based on 13F filing dates vs. subsequent ELDN price moves, Blue Owl Capital Holdings LP correctly timed 3 out of 5 reported position changes (60%). The annualised alpha on ELDN relative to SPY over the holding period was -24.9%.

← Back to Blue Owl Capital Holdings LP Holdings